CurrentEndo
Get Weekly

Topic · page 5 of 16

Endocrine oncology

Thyroid cancer including radioiodine treatment and treatment of advanced disease, adrenocortical carcinoma, metastatic pheochromocytoma and paraganglioma, multiple endocrine neoplasia, neuroendocrine tumors, functioning or not

Briefs 161–200 of 606 placed here, newest publication first

Briefs in Endocrine oncology

Newest publication first

  1. Eur J Endocrinol

    External validation of the S-GRAS score for predicting recurrence in patients with adrenocortical carcinoma: implications for adjuvant mitotane therapy

    Diagnostic or prognostic study

  2. J Clin Endocrinol Metab

    TSH Cutoffs and Recurrence Risk in Differentiated Thyroid Carcinomas: A Systematic Review and Meta-Analysis

    Meta-analysis

  3. Thyroid

    Neoadjuvant Therapy with Multikinase Inhibitors for Locally Advanced Differentiated Thyroid Cancer: A Systematic Review

    Meta-analysis

  4. Clin Endocrinol (Oxf)

    Exploring the Molecular Features and Clinicopathological Correlations of Diffuse Sclerosing Papillary Thyroid Carcinoma

    Cohort study

  5. Thyroid

    Dynamic Risk Assessment Using Unstimulated Serum Thyroglobulin Level and Thyroglobulin Doubling Rate after Total Thyroidectomy for Papillary Thyroid Carcinoma

    Cohort study

  6. J Clin Endocrinol Metab

    Efficacy and Safety of Radiotherapy and Systemic Treatments in Adrenocortical Carcinoma: Systematic Review and Meta-Analysis

    Meta-analysis

  7. Endocr Pract

    Deep Learning for the Diagnosis and Treatment of Thyroid Cancer: A Review

    Meta-analysis

  8. Thyroid

    Clinical and Pathological Factors Associated with Disease Persistence in Pediatric Patients with Differentiated Thyroid Carcinoma

    Cohort study

  9. Thyroid

    Trends in Survival and Factors Associated with Survival in Primary Thyroid Lymphoma: A SEER-Based Analysis (1975–2021)

    Cohort study

  10. Eur Thyroid J

    Risk-adapted therapy in pediatric thyroid cancer: initial experience from a national reference program by the MET group

    Cohort study

  11. Eur Thyroid J

    Differentiated thyroid cancer in two European referral centres: impact of different diagnostic and therapeutic strategies

    Cohort study

  12. Endocr Pract

    Prognostic Factors and Survival Outcomes in Thyroid Cancer Patients With Bone Metastasis: Insights From a Population-Based Cohort Study

    Cohort study

  13. J Clin Endocrinol Metab

    Long-term Survivors of Anaplastic Thyroid Cancer: A Genomic Predictive Model

    Cohort study

  14. Thyroid

    Thyroid Cancer Survivors Experience Persistent Symptoms and Health-Related Quality-of-Life Deficits 12 Months Following Surgery

    Cohort study

  15. Clin Endocrinol (Oxf)

    Glucagonoma and Glucagonoma Syndrome: An Updated Review

    Research article

  16. Eur J Endocrinol

    Progression of potentially aggressive pituitary neuroendocrine tumors after radiotherapy: risk factors, management, and outcomes

    Cohort study

  17. Thyroid

    Adjuvant Pembrolizumab after Upfront Multimodal Therapy for Stage IVB Anaplastic Thyroid Cancer

    Meta-analysis

  18. Thyroid

    Deep Learning Discovers New Morphological Features while Predicting Genetic Alterations from Histopathology of Papillary Thyroid Carcinoma

    Diagnostic or prognostic study

  19. Thyroid

    Progastrin-Releasing Peptide and Procalcitonin as Additional Markers in the Diagnostic Workup for Medullary Thyroid Carcinoma

    Diagnostic or prognostic study

  20. J Clin Endocrinol Metab

    Characterization of Advanced RAS -driven Follicular-derived Thyroid Cancers and Review of Future Therapeutic Avenues

    Cohort study

  21. Eur J Endocrinol

    Mitotane treatment of adrenocortical carcinoma induces tumoural secretion of GDF-15: impact on poor prognosis and impaired responsiveness to immunotherapy

    Cohort study

  22. Clin Endocrinol (Oxf)

    Endocrine Implications of Thyroid Incidentalomas Detected During Lymphoma Staging With 18F‐Fluorodeoxyglucose Positron Emission Tomography

    Cohort study

  23. J Clin Endocrinol Metab

    Circulating Gene Expression Assay as a Diagnostic and Prognostic Biomarker for Pancreatic Neuroendocrine Tumors in MEN1

    Cohort study

  24. Eur J Endocrinol

    Autoimmune thyroiditis in paediatric thyroid cancer: clinical features and outcomes

    Cohort study

  25. Lancet

    Thyroidectomy with or without postoperative radioiodine for patients with low-risk differentiated thyroid cancer in the UK (IoN): a randomised, multicentre, non-inferiority trial

    Randomized controlled trial

  26. Eur Thyroid J

    Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancer

    Cohort study

  27. Eur Thyroid J

    Molecular predictive biomarker testing in advanced thyroid cancer – a European consensus

    Guideline or statement

  28. Clin Endocrinol (Oxf)

    The Efficacy and Safety of Pembrolizumab in Anaplastic Thyroid Carcinoma: A Systematic Review and Meta‐Analysis

    Meta-analysis

  29. Lancet Diabetes Endocrinol

    Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practice

    Guideline or statement

  30. Lancet Diabetes Endocrinol

    Treatments for MEN1-associated endocrine tumours: three systematic reviews and a meta-analysis

    Meta-analysis

  31. Eur J Endocrinol

    Revised European Society of Endocrinology Clinical Practice Guideline for the management of aggressive pituitary tumours and pituitary carcinomas

    Guideline or statement

  32. J Clin Endocrinol Metab

    Multiple or Single Endocrine Abnormalities Associated With Immune Checkpoint Inhibitors

    Cohort study

  33. Thyroid

    Long-Term Clinical Outcomes of Patients with Differentiated Thyroid Cancer Treated with Lenvatinib: Results from Real-World Practice in Japan

    Cohort study

  34. Endocr Pract

    Undetectable Serum Thyroglobulin in Patients With Differentiated Thyroid Cancer: Antithyroglobulin Antibodies, Assay Limitation, or Other?

    Mechanistic study

  35. Clin Endocrinol (Oxf)

    CD105 (Endoglin) Expression as a Prognostic Marker in Aggressive Papillary Thyroid Carcinoma

    Cohort study

  36. Clin Endocrinol (Oxf)

    Combining Procalcitonin and Calcitonin for the Diagnosis of Medullary Thyroid Cancer: A Two‐Step Approach

    Diagnostic or prognostic study

  37. J Clin Endocrinol Metab

    Clinical Significance of Successful Ablation in Follicular Thyroid Carcinoma

    Cohort study

  38. Endocr Pract

    Perineural Invasion Is Not an Independent Risk Factor for Recurrence and Lateral Neck Metastasis in Thyroid Cancer: A Propensity Score Matching Analysis

    Cohort study

  39. JAMA Netw Open

    Epidemiology of Neuroendocrine Neoplasms in the US

    Cross-sectional study

  40. JAMA Netw Open

    Medullary Thyroid Cancer Risk and Mortality in Carriers of Incidentally Identified MEN2A RET Variants

    Cohort study

All 606 Briefs in ExploreShowing Briefs 161–200 of 606, newest first